Effects of Ginger on clinical manifestations and paraclinical features of patients due to COVID-19

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200059824

Enrollment

Unknown

Registered

2022-05-12

Start date

2022-05-01

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel coronavirus infectious diseases

Interventions

Intervention group:Ginger powder before breakfast and lunch + routine treatment

Control group:Routine treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Nucleic acid test positive, asymptomatic or wind cold symptoms such as fear of cold and gastrointestinal reaction were taken as the inclusion criteria.

Exclusion criteria

Exclusion criteria: 1. Those with wind heat symptoms such as sore throat and fever.

Design outcomes

Primary

Measure	Time frame
Nucleic acid negative time;Rehabilitation rate;	—

Countries

China

Contacts

Public ContactSong Yuanlin

Zhongshan Hospital Affiliated to Fudan University

ylsong70@163.com+86 15021757762

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026